Adiponectin and progression of arterial stiffness in hypertensive patients

Jong Chan Youn, Changsoo Kim, Sungha Park, Sang Hak Lee, seokmin kang, Donghoon Choi, Nak Hoon Son, Dong Jik Shin, Yangsoo Jang

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Recent studies suggest that adiposity is associated with arterial stiffness. However, it is unclear which adipokine or what adiposity related parameters are related with the progression of arterial stiffness. We hypothesized that in hypertensive patients, initial levels of adipokines such as adiponectin and resistin are related to the progression of arterial stiffness, which has been proven to be associated with increased risk of cardiovascular events. Methods: One hundred forty one consecutive patients with treated essential hypertension (81 men, 57.7 ± 8.2 years) were enrolled. Pulse wave velocity (PWV) was measured at baseline, and after 24 months. Clinical variables and laboratory findings at the time of initial enrollment were analyzed to reveal the determinants of arterial stiffening. Results: Mean heart to femoral PWV (hfPWV) was 992 ± 202 cm/s at baseline, and 1021 ± 263 cm/s at 24 months follow up. hfPWV progressed in seventy two patients (51.1%) during follow up period. In patients with hfPWV progression, mean plasma adiponectin level was significantly lower than patients with nonprogression (progressor: 5.18 ± 3.21 μg/ml, non-progressor: 7.02 ± 5.19 μg/ml, p = 0.013). Multivariate regression analysis revealed plasma adiponectin level to being an independent predictor of hfPWV changes (ß = - 0.018, p = 0.032) when controlled for age, gender, SBP changes, BP control and HOMA. Conclusions: Plasma adiponectin levels are associated with progression of arterial stiffness in hypertensive patients. These findings may be one explanation for the high association between adiposity and arterial stiffness in hypertensive patients.

Original languageEnglish
Pages (from-to)316-319
Number of pages4
JournalInternational Journal of Cardiology
Volume163
Issue number3
DOIs
Publication statusPublished - 2013 Mar 10

Fingerprint

Vascular Stiffness
Adiponectin
Thigh
Adiposity
Pulse Wave Analysis
Adipokines
Resistin
Multivariate Analysis
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{abb9f627e5b14ffea0dd21751d9026e4,
title = "Adiponectin and progression of arterial stiffness in hypertensive patients",
abstract = "Background: Recent studies suggest that adiposity is associated with arterial stiffness. However, it is unclear which adipokine or what adiposity related parameters are related with the progression of arterial stiffness. We hypothesized that in hypertensive patients, initial levels of adipokines such as adiponectin and resistin are related to the progression of arterial stiffness, which has been proven to be associated with increased risk of cardiovascular events. Methods: One hundred forty one consecutive patients with treated essential hypertension (81 men, 57.7 ± 8.2 years) were enrolled. Pulse wave velocity (PWV) was measured at baseline, and after 24 months. Clinical variables and laboratory findings at the time of initial enrollment were analyzed to reveal the determinants of arterial stiffening. Results: Mean heart to femoral PWV (hfPWV) was 992 ± 202 cm/s at baseline, and 1021 ± 263 cm/s at 24 months follow up. hfPWV progressed in seventy two patients (51.1{\%}) during follow up period. In patients with hfPWV progression, mean plasma adiponectin level was significantly lower than patients with nonprogression (progressor: 5.18 ± 3.21 μg/ml, non-progressor: 7.02 ± 5.19 μg/ml, p = 0.013). Multivariate regression analysis revealed plasma adiponectin level to being an independent predictor of hfPWV changes ({\ss} = - 0.018, p = 0.032) when controlled for age, gender, SBP changes, BP control and HOMA. Conclusions: Plasma adiponectin levels are associated with progression of arterial stiffness in hypertensive patients. These findings may be one explanation for the high association between adiposity and arterial stiffness in hypertensive patients.",
author = "Youn, {Jong Chan} and Changsoo Kim and Sungha Park and Lee, {Sang Hak} and seokmin kang and Donghoon Choi and Son, {Nak Hoon} and Shin, {Dong Jik} and Yangsoo Jang",
year = "2013",
month = "3",
day = "10",
doi = "10.1016/j.ijcard.2011.06.061",
language = "English",
volume = "163",
pages = "316--319",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

Adiponectin and progression of arterial stiffness in hypertensive patients. / Youn, Jong Chan; Kim, Changsoo; Park, Sungha; Lee, Sang Hak; kang, seokmin; Choi, Donghoon; Son, Nak Hoon; Shin, Dong Jik; Jang, Yangsoo.

In: International Journal of Cardiology, Vol. 163, No. 3, 10.03.2013, p. 316-319.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adiponectin and progression of arterial stiffness in hypertensive patients

AU - Youn, Jong Chan

AU - Kim, Changsoo

AU - Park, Sungha

AU - Lee, Sang Hak

AU - kang, seokmin

AU - Choi, Donghoon

AU - Son, Nak Hoon

AU - Shin, Dong Jik

AU - Jang, Yangsoo

PY - 2013/3/10

Y1 - 2013/3/10

N2 - Background: Recent studies suggest that adiposity is associated with arterial stiffness. However, it is unclear which adipokine or what adiposity related parameters are related with the progression of arterial stiffness. We hypothesized that in hypertensive patients, initial levels of adipokines such as adiponectin and resistin are related to the progression of arterial stiffness, which has been proven to be associated with increased risk of cardiovascular events. Methods: One hundred forty one consecutive patients with treated essential hypertension (81 men, 57.7 ± 8.2 years) were enrolled. Pulse wave velocity (PWV) was measured at baseline, and after 24 months. Clinical variables and laboratory findings at the time of initial enrollment were analyzed to reveal the determinants of arterial stiffening. Results: Mean heart to femoral PWV (hfPWV) was 992 ± 202 cm/s at baseline, and 1021 ± 263 cm/s at 24 months follow up. hfPWV progressed in seventy two patients (51.1%) during follow up period. In patients with hfPWV progression, mean plasma adiponectin level was significantly lower than patients with nonprogression (progressor: 5.18 ± 3.21 μg/ml, non-progressor: 7.02 ± 5.19 μg/ml, p = 0.013). Multivariate regression analysis revealed plasma adiponectin level to being an independent predictor of hfPWV changes (ß = - 0.018, p = 0.032) when controlled for age, gender, SBP changes, BP control and HOMA. Conclusions: Plasma adiponectin levels are associated with progression of arterial stiffness in hypertensive patients. These findings may be one explanation for the high association between adiposity and arterial stiffness in hypertensive patients.

AB - Background: Recent studies suggest that adiposity is associated with arterial stiffness. However, it is unclear which adipokine or what adiposity related parameters are related with the progression of arterial stiffness. We hypothesized that in hypertensive patients, initial levels of adipokines such as adiponectin and resistin are related to the progression of arterial stiffness, which has been proven to be associated with increased risk of cardiovascular events. Methods: One hundred forty one consecutive patients with treated essential hypertension (81 men, 57.7 ± 8.2 years) were enrolled. Pulse wave velocity (PWV) was measured at baseline, and after 24 months. Clinical variables and laboratory findings at the time of initial enrollment were analyzed to reveal the determinants of arterial stiffening. Results: Mean heart to femoral PWV (hfPWV) was 992 ± 202 cm/s at baseline, and 1021 ± 263 cm/s at 24 months follow up. hfPWV progressed in seventy two patients (51.1%) during follow up period. In patients with hfPWV progression, mean plasma adiponectin level was significantly lower than patients with nonprogression (progressor: 5.18 ± 3.21 μg/ml, non-progressor: 7.02 ± 5.19 μg/ml, p = 0.013). Multivariate regression analysis revealed plasma adiponectin level to being an independent predictor of hfPWV changes (ß = - 0.018, p = 0.032) when controlled for age, gender, SBP changes, BP control and HOMA. Conclusions: Plasma adiponectin levels are associated with progression of arterial stiffness in hypertensive patients. These findings may be one explanation for the high association between adiposity and arterial stiffness in hypertensive patients.

UR - http://www.scopus.com/inward/record.url?scp=84874540019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874540019&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2011.06.061

DO - 10.1016/j.ijcard.2011.06.061

M3 - Article

C2 - 21724272

AN - SCOPUS:84874540019

VL - 163

SP - 316

EP - 319

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -